Strontium-incorporated bioceramic scaffolds for enhanced osteoporosis bone regeneration
Qianju Wu , Longwei Hu , Ran Yan , Junfeng Shi , Hao Gu , Yuwei Deng , Ruixue Jiang , Jin Wen , Xinquan Jiang
Bone Research ›› 2022, Vol. 10 ›› Issue (1) : 55
Strontium-incorporated bioceramic scaffolds for enhanced osteoporosis bone regeneration
The restoration of bone defects caused by osteoporosis remains a challenge for surgeons. Strontium ranelate has been applied in preventative treatment approaches due to the biological functions of the trace element strontium (Sr). In this study, we aimed to fabricate bioactive scaffolds through Sr incorporation based on our previously developed modified amino-functional mesoporous bioactive glass (MBG) and to systematically investigate the bioactivity of the resulting scaffold in vitro and in vivo in an osteoporotic rat model. The results suggested that Sr-incorporated amino-functional MBG scaffolds possessed favorable biocompatibility. Moreover, with the incorporation of Sr, osteogenic and angiogenic capacities were upregulated in vitro. The in vivo results showed that the Sr-incorporated amino-functional MBG scaffolds achieved better bone regeneration and vessel formation. Furthermore, bioinformatics analysis indicated that the Sr-incorporated amino-functional MBG scaffolds could reduce reactive oxygen species levels in bone marrow mesenchymal stem cells in the osteoporotic model by activating the cAMP/PKA signaling pathway, thus playing an anti-osteoporosis role while promoting osteogenesis. This study demonstrated the feasibility of incorporating trace elements into scaffolds and provided new insights into biomaterial design for facilitating bone regeneration in the treatment of osteoporosis.
| [1] |
|
| [2] |
|
| [3] |
|
| [4] |
|
| [5] |
|
| [6] |
Baino, F., Hamzehlou, S. & Kargozar, S. Bioactive glasses: where are we and where are we going? J. Funct. Biomater. 9, (2018). |
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
Yahiro, Y. et al. BMP-induced Atoh8 attenuates osteoclastogenesis by suppressing Runx2 transcriptional activity and reducing the Rankl/Opg expression ratio in osteoblasts. Bone Res. 8, (2020). |
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
|
| [24] |
|
| [25] |
|
| [26] |
|
| [27] |
|
| [28] |
|
| [29] |
|
| [30] |
|
| [31] |
|
| [32] |
|
| [33] |
|
| [34] |
Tronolone, J.J. & Jain, A. Engineering new microvascular networks on-chip: ingredients, assembly, and best practices. Adv. Funct. Mater. 31, (2021). |
| [35] |
|
| [36] |
|
| [37] |
|
| [38] |
|
| [39] |
|
| [40] |
|
| [41] |
Park, H.J., Gholam-Zadeh, M., Yoon, S.Y., Suh, J.H. & Choi, H.S. Estrogen decreases cytoskeletal organization by forming an ERalpha/SHP2/c-Src complex in osteoclasts to protect against ovariectomy-induced bone loss in mice. Antioxidants 10 (2021). |
| [42] |
Wu, B. et al. The receptor-like cytosolic kinase RIPK activates NADP-malic enzyme 2 to generate NADPH for fueling the ROS production. Mol. Plant (2022). |
| [43] |
|
| [44] |
|
| [45] |
|
| [46] |
|
| [47] |
|
| [48] |
|
| [49] |
|
| [50] |
|
| [51] |
|
| [52] |
|
| [53] |
|
| [54] |
|
National Natural Science Foundation of China (National Science Foundation of China)(81921002)
/
| 〈 |
|
〉 |